{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-009282","form_type":"8-K","ticker":"NXTC","cik":"0001661059","company_name":"NextCure, Inc.","filed_at":"2024-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.476161+00:00","generated_at":"2026-06-01T03:54:56.346913+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NextCure CMO Han Myint retires July 1; becomes consultant through 2025","bullets":["Dr. Han Myint retires as CMO effective July 1, 2024; will provide consulting services starting July 2, 2024 on clinical trials and join Scientific Advisory Board.","The Company will provide continued salary and healthcare benefits through March 31, 2025.","Equity awards continue to vest during the consulting term; exercisability period extended to 90 days after term expiration.","Consulting agreement initial term through July 2, 2025, auto-renewing annually unless terminated by either party."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-009282","json":"https://secwatch.observer/filing/0001558370-24-009282.json","markdown":"https://secwatch.observer/filing/0001558370-24-009282.md","text":"https://secwatch.observer/filing/0001558370-24-009282.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661059/000155837024009282/0001558370-24-009282-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661059/000155837024009282/nxtc-20240618x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:54:56.346913+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c1c38b4dc5","claim":"Han Myint retired as Chief Medical Officer at NextCure, Inc..","evidence_excerpt":"Dr. Han Myint, M.D. notified NextCure, Inc. (the “Company”) of his plan to retire from his position as Chief Medical Officer of the Company, effective July 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661059/000155837024009282/0001558370-24-009282-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}